Achieving Innovation in CLL Care Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Expert hematologists/oncologists and a passionate patient advocate discuss ways to improve outcomes in the relapsed/refractory setting of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL). Considerations for collaborative treatment decision-making between oncology teams and their patients will be shared. This archived webinar, conducted in partnership with the Leukemia & Lymphoma Society (LLS) and The CLL Society, illustrates real-world patient survey data collected by PRIME to support patient-centered care approaches.
Related posts
